EMA – Translating innovation into access for ATMPs: 3rd EU-Innovation network multi-stakeholder meeting – 15 November 2024
The EU-Innovation Network (EU-IN) and the Italian Medicines Agency (AIFA) are organising a multi-stakeholder meeting to discuss how innovation in the development of Advanced Therapy Medicinal Products (ATMPs) can be translated into effective and safe therapies at the point of care in Europe.
The objectives are:
- seek feedback from developers on the main challenges and barriers currently encountered from early development to access,
- provide insights on scientific and regulatory advice tools at European and national level available for developers,
- discuss opportunities for promoting mutual exchange and interactions between stakeholders with the aim of strengthening the European Innovation Ecosystem.
More information on this event on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (21 octobre 2024). EMA – Translating innovation into access for ATMPs: 3rd EU-Innovation network multi-stakeholder meeting – 15 November 2024. ELSIBI. Consulté le 7 octobre 2026 à l’adresse https://doi.org/10.58079/12jhu
